JAMA Oncology
@jamaonc
JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
ID: 2811548749
http://ja.ma/tjamaoncology 15-09-2014 15:33:04
18,18K Tweet
47,47K Followers
513 Following
Most viewed this week from JAMA Oncology: While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4jyRiED
